EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Vagus Nerve Stimulation Modulates Inflammation in Treatment-Resistant Depression Patients: A Pilot Study

Paul Lespérance, Véronique Desbeaumes Jodoin iD, David Drouin, Frédéric Racicot, Jean-Philippe Miron iD, Christophe Longpré-Poirier iD, Marie-Pierre Fournier-Gosselin, Paméla Thebault, Réjean Lapointe, Nathalie Arbour, Jean-François Cailhier iD

International Journal of Molecular Sciences · 26.02.2024 · 25 (5) · 2679

DOI: 10.3390/ijms25052679 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 26.02.2024. Verfasst von Paul Lespérance und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Centre Hospitalier de l'Université de Montréal (CHUM), Université de Montréal, Montreal, QC H2X 0C1, Canada. Hauptthemen laut MEDLINE: Vagus Nerve Stimulation, Depressive Disorder, Treatment-Resistant. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chair Claude-Bertrand, University of Montreal, Chair Claude-Bertrand in neurosurgery of the Université de Montréal.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Vagal neurostimulation (VNS) is used for the treatment of epilepsy and major medical-refractory depression. VNS has neuropsychiatric functions and systemic anti-inflammatory activity. The objective of this study is to measure the clinical efficacy and impact of VNS modulation in depressive patients. Six patients with refractory depression were enrolled. Depression symptoms were assessed with the Montgomery–Asberg Depression Rating, and anxiety symptoms with the Hamilton Anxiety Rating Scale. Plasmas were harvested prospectively before the implantation of VNS (baseline) and up to 4 years or more after continuous therapy. Forty soluble molecules were measured in the plasma by multiplex assays. Following VNS, the reduction in the mean depression severity score was 59.9% and the response rate was 87%. Anxiety levels were also greatly reduced. IL-7, CXCL8, CCL2, CCL13, CCL17, CCL22, Flt-1 and VEGFc levels were significantly lowered, whereas bFGF levels were increased (p values ranging from 0.004 to 0.02). This exploratory study is the first to focus on the long-term efficacy of VNS and its consequences on inflammatory biomarkers. VNS may modulate inflammation via an increase in blood–brain barrier integrity and a reduction in inflammatory cell recruitment. This opens the door to new pathways involved in the treatment of refractory depression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vagus Nerve StimulationDepressive Disorder, Treatment-ResistantHumansPilot ProjectsDepressionTreatment OutcomeInflammation

Stichwörter der Autor:innen

blood–brain barrierinflammationmajor depressionneuromodulation

Autor:innen und Institutionen

  • Department of Psychiatry, Centre Hospitalier de l'Université de Montréal (CHUM), Université de Montréal, Montreal, QC H2X 0C1, Canada.
  • Department of Medicine, Université de Montréal, Montreal, QC H3T 1J4, Canada.
  • Division of Neurosurgery, CHUM, Université de Montréal, Montreal, QC H2X 0C1, Canada.
  • Centre de Recherche du CHUM (CRCHUM), Institut du Cancer de Montréal, Montreal, QC H2X 0A9, Canada.
  • Department of Neurosciences, Université de Montréal and CRCHUM, Montreal, QC H2X 0A9, Canada.
  • Department of Medicine, Renal Division, CHUM, Université de Montréal, Montreal, QC H2X 0C1, Canada.

ORCID-Profile: Véronique Desbeaumes Jodoin, Jean-Philippe Miron, Christophe Longpré-Poirier, Jean-François Cailhier

Förderung

  • Chair Claude-Bertrand, University of Montreal
  • Chair Claude-Bertrand in neurosurgery of the Université de Montréal

Zitieren

APA

Lespérance, P., Desbeaumes Jodoin, V., Drouin, D., Racicot, F., Miron, J. P., Longpré-Poirier, C., Fournier-Gosselin, M. P., Thebault, P., Lapointe, R., Arbour, N., & Cailhier, J. F. (2024). Vagus Nerve Stimulation Modulates Inflammation in Treatment-Resistant Depression Patients: A Pilot Study. International Journal of Molecular Sciences, 25(5), 2679. https://doi.org/10.3390/ijms25052679

Vancouver

Lespérance P, Desbeaumes Jodoin V, Drouin D, Racicot F, Miron JP, Longpré-Poirier C, et al. Vagus Nerve Stimulation Modulates Inflammation in Treatment-Resistant Depression Patients: A Pilot Study. International Journal of Molecular Sciences. 2024;25(5):2679. doi:10.3390/ijms25052679

BibTeX
@article{Lesprance2024,
  author = {Lespérance, Paul and Desbeaumes Jodoin, Véronique and Drouin, David and Racicot, Frédéric and Miron, Jean-Philippe and Longpré-Poirier, Christophe and Fournier-Gosselin, Marie-Pierre and Thebault, Paméla and Lapointe, Réjean and Arbour, Nathalie and Cailhier, Jean-François},
  title = {Vagus Nerve Stimulation Modulates Inflammation in Treatment-Resistant Depression Patients: A Pilot Study},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {5},
  pages = {2679},
  doi = {10.3390/ijms25052679}
}
Kostenlos starten →